The Valley Desk

NCT01137474 · Interventional trial

A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker

Overall registry status Completed

Phase 3

Conditions Type 2 Diabetes

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov